Medicamen Biotech Limited

Web: medicamen.com NSE: MEDICAMEQ BSE: 531146 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

241 4(-2%)

Volume

77k as on 23, Jun

Open

520

High

521

Low

506

245

VWAP

240

52 Week High

448

52 Week Low

212

Viand Research Rating

Quality Score

58/100

Growth Score

49/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

327

No. of Shares

1.36

P/E

53.7

P/B

2.67

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

4.97

ROCE

Profit Growth

Listing Date

27-Oct-21

Promoter Holding

40.46%

FII Holding

0.1%

DII Holding

Price Chart

Price Performance

1 Week6%

1 Month10%

3 Months1%

6 Months17%

1 Year17%

YTD17%

Moving Average

5 Day SMA230

10 Day SMA229

20 Day SMA244

30 Day SMA254

50 Day SMA258

61 Day SMA253

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	233	229	231	236
Resistance 2	231	229	230	233
Resistance 1	230	228	229	233
Pivot Point	228	228	228	229
Support 1	226	228	227	229
Support 2	224	227	226	226
Support 3	223	227	224	226

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Apr 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 40.46%	(0.01) 40.46%	(0.01) 40.46%	(0.01) 40.46%	(-2.71) 40.46%	(0.21) 43.16%	(0.01) 42.99%	(0.01) 42.99%	(-0.21) 42.99%	(0.01) 43.21%	(0.01) 43.21%	(0.01) 43.21%	(0.01) 43.21%	(0.01) 43.21%	(0.01) 43.21%	(-0.41) 43.21%	(0.01) 43.60%	(0.01) 43.60%	(-1.21) 43.60%	(0.01) 44.83%
FIIs	(0.11) 0.10%	(0.01) 0.02%	(0.11) 0.05%	(-0.21) 0.00%	(0.11) 0.22%	(0.11) 0.12%	(0.01) 0.06%	(0.01) 0.06%	(-0.11) 0.06%	(-0.11) 0.12%	(0.01) 0.22%	(0.11) 0.22%	(0.01) 0.16%	(0.01) 0.19%	(-1.71) 0.17%	(1.51) 1.83%	(-0.11) 0.35%	(0.11) 0.40%	(0.01) 0.35%	(0.01) 0.35%
DIIs	(-0.41) 0.00%	(-0.21) 0.44%	(-0.11) 0.59%	(0.01) 0.64%	(0.01) 0.65%	(-0.21) 0.69%	(-0.31) 0.87%	(0.01) 1.17%	(0.21) 1.17%	(0.31) 0.99%	(0.51) 0.67%	(0.01) 0.20%	(0.01) 0.20%	(0.01) 0.20%	(0.11) 0.20%	(0.11) 0.13%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Government	0.05%	0.05%	0.05%	0.05%	0.05%	0.06%	0.06%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	59.39%	59.02%	58.84%	58.83%	58.62%	55.99%	56.04%	55.79%	55.78%	55.69%	55.90%	56.38%	56.44%	56.40%	56.42%	54.84%	56.06%	56.01%	56.06%	54.82%
No. of Shareholders	10,806	10,967	11,177	10,808	10,592	10,435	10,576	10,792	10,652	10,639	10,252	9,419	8,272	8,233	8,273	8,332	9,107	9,300	9,140	5,595

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	60.65	46.91	47.17	43.04	29.61	45.14	44.74	43.05	47.32	46.5	43.54	41.94	38.67	35.58	33.53	33.09	22.75	32.64	32.52	27.53
Sales Growth % (YoY)	105%	4%	5%	-	-37%	-3%	3%	3%	22%	31%	30%	27%	70%	9%	3.1%	20.2%	7.1%	-0.8%	5.7%	-0.9%
Sales Growth % (QoQ)	29.3%	-0.6%	9.6%	45.4%	-34.4%	0.9%	3.9%	-9%	1.8%	6.8%	3.8%	8.5%	8.7%	6.1%	1.3%	45.5%	-30.3%	0.4%	18.1%	-
Expenses	55.22	42.53	42.01	38.43	31.22	38.43	39.43	39.6	41.57	41.6	38.89	34.99	32.18	29.71	27.67	27.43	17.79	26.34	26.3	21.49
Operating Profit	5.43	4.38	5.16	4.61	-1.61	6.71	5.31	3.45	5.75	4.9	4.65	6.95	6.49	5.87	5.86	5.66	4.96	6.3	6.22	6.04
OPM %	8.95	9.34	10.94	10.71	-5.44	14.86	11.87	8.01	12.15	10.54	10.68	16.57	16.78	16.5	17.48	17.1	21.8	19.3	19.13	21.94
Other Income	1.74	0.53	0.37	0.47	5.23	0.14	0.29	0.59	0.57	0.83	0.55	0.38	0.35	0.63	0.52	0.96	0.34	0.83	0.48	0.08
Interest	0.38	0.97	0.99	1.15	0.65	0.76	1.04	0.71	1.89	0.65	0.91	0.96	0.86	0.68	0.62	0.77	0.56	0.49	0.3	0.04
Depreciation	1.73	1.83	1.86	1.8	0.48	2.21	2.61	1.77	1.77	1.8	1.82	1.69	1.62	1.6	1.62	1.53	1.52	1.57	1.35	1.33
Profit before tax	5.06	2.11	2.68	2.13	2.49	3.88	1.95	1.56	2.66	3.28	2.47	4.68	4.36	4.22	4.14	4.32	3.22	5.07	5.05	4.75
Tax %	12.06	22.27	21.27	24.88	25.3	24.74	53.85	48.72	22.93	38.11	39.68	15.81	13.53	10.66	13.04	17.13	14.6	25.64	16.44	12.42
Net Profit	4.45	1.64	2.12	1.6	1.87	2.92	0.91	0.8	2.04	2.03	1.47	3.95	3.77	3.77	3.6	3.59	2.75	3.78	4.22	4.15
Net Profit Growth % (QoQ)	171.3%	-22.6%	32.5%	-14.4%	-36%	220.9%	13.7%	-60.8%	0.5%	38.1%	-62.8%	4.8%	-	4.7%	0.3%	30.5%	-27.2%	-10.4%	1.7%	-
Net Profit Growth % (YoY)	138%	-43.8%	133%	100%	-8.3%	43.8%	-38.1%	-79.7%	-45.9%	-46.2%	-59.2%	10%	37.1%	-0.3%	-14.7%	-13.5%	-	-	-	-
TTM Net Profit	9.81	7.23	8.51	7.3	6.5	6.67	5.78	6.34	9.49	11.22	12.96	15.09	14.73	13.71	13.72	14.34	14.9	12.15	8.37	0
EPS in Rs	2.85	1.61	1.97	1.59	1.9	2.73	1.15	1.06	1.68	1.9	1.19	3.3	3.07	2.97	2.85	2.94	2.25	3.09	3.45	3.4

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Sales	198	163	179	141	115	113	125	123
Sales Growth %	21.7%	-9.3%	27.3%	22%	2.4%	-10.2%	2.4%	-
Expenses	178	148	156	117	91	93	106	105
Operating Profit	20	14	24	24	24	20	20	17
OPM %	10	9	13	17	21	17	16	14
Other Income	3	6	2	2	2	1	2	4
Interest	4	4	6	3	2	2	1	1
Depreciation	7	7	7	6	6	3	2	2
Profit before tax	12	10	13	17	18	16	18	18
Tax %	18	34	27	14	18	26	26	31
Net Profit	10	7	9	15	15	12	13	12
Net Profit Growth %	42.9%	-22.2%	-40%	-	25%	-7.7%	8.3%	-
EPS in Rs	7.11	5.59	8.6	11.73	12.2	9.93	10.88	10.28
Dividend Payout %	14	18	12	9	8	10	5	10

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash from Operating Activity	-33	-8	-7	-6	4	13	13	4
Cash from Investing Activity	-3	-1	-6	-6	-8	-18	-37	-15
Cash from Financing Activity	64	-1	6	29	4	6	19	-4
Net Cash Flow	28	-11	-6	17	0	1	-5	-14

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Equity Capital	14	14	13	13	13	13	12	12	12	12
Reserves	262	262	200	203	194	181	134	121	109	75
Borrowings	48	39	34	20	31	26	26	19	11	12
Other Liabilities	49	53	50	52	56	59	53	42	49	38
Total Liabilities	372	367	297	289	295	279	226	194	181	137
Fixed Assets	85	86	87	89	92	93	92	90	34	24
CWIP	0	0	0	0	0	0	0	0	40	15
Investments	0	8	0	0	0	0	0	0	0	0
Other Assets	287	273	210	200	203	186	133	104	107	97
Total Assets	372	367	297	289	295	279	226	194	181	137

Delivery

#	Date	212 42% 301	Value (Cr)	Q/T 43	Del 57	Del 1
1	22-Jul	245	0	26	67	0
2	21-Jul	249	1	41	61	1
3	20-Jul	236	0	23	65	0
4	17-Jul	239	0	19	64	0
5	16-Jul	238	0	14	70	0
6	15-Jul	237	0	19	63	0
7	14-Jul	233	0	23	67	0
8	13-Jul	238	1	25	63	0
9	10-Jul	245	0	31	80	0
10	9-Jul	245	1	28	58	0
11	8-Jul	251	1	34	66	1
12	7-Jul	247	1	22	55	0
13	6-Jul	256	0	29	78	0
14	3-Jul	261	1	19	59	0
15	2-Jul	257	1	21	67	0
16	1-Jul	263	3	26	41	1
17	30-Jun	250	5	33	37	2
18	29-Jun	241	2	36	57	1
19	25-Jun	228	1	37	78	0
20	24-Jun	229	1	52	88	1
21	23-Jun	242	2	36	53	1
22	22-Jun	228	0	38	76	0
23	19-Jun	229	0	29	71	0
24	18-Jun	226	1	33	60	0
25	17-Jun	224	1	32	76	0
26	16-Jun	228	1	29	65	0
27	15-Jun	225	1	37	75	1
28	12-Jun	230	0	23	66	0
29	11-Jun	224	0	22	66	0
30	10-Jun	230	1	20	35	0
31	9-Jun	240	2	20	26	0
32	8-Jun	224	1	33	62	1
33	5-Jun	246	1	20	40	0
34	4-Jun	256	0	22	68	0
35	3-Jun	266	0	24	61	0
36	2-Jun	273	0	45	76	0
37	1-Jun	270	1	38	74	1
38	29-May	272	2	36	61	1
39	27-May	285	2	73	66	1
40	26-May	272	0	21	76	0
41	25-May	271	0	25	50	0
42	22-May	270	0	26	66	0
43	21-May	267	0	24	54	0
44	20-May	274	0	32	76	0
45	19-May	269	0	24	73	0
46	18-May	269	0	20	60	0
47	15-May	277	0	30	66	0
48	14-May	272	1	19	39	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	327c	9c	2.67
22-Jul	336c	3c	0.92
21-Jul	333c	11c	3.44
17-Jul	322c	3c	0.79
16-Jul	324c	2c	0.55
15-Jul	322c	4c	1.19
14-Jul	319c	3c	1.03
13-Jul	322c	18c	5.38
10-Jul	340c	7c	2.20
09-Jul	333c	10c	3.00
08-Jul	343c	8c	2.51
07-Jul	335c	9c	2.64
06-Jul	344c	17c	4.81
02-Jul	361c	6c	1.66
01-Jul	355c	14c	4.01
30-Jun	342c	24c	7.56
29-Jun	318c	10c	3.08
26-Jun	308c	68L	0.22
25-Jun	309c	3c	1.00
24-Jun	312c	15c	4.56
23-Jun	327c	18c	5.79
22-Jun	309c	3c	0.81
19-Jun	312c	10c	3.33
18-Jun	301c	1c	0.34
17-Jun	303c	7c	2.19
16-Jun	309c	5c	1.79
15-Jun	304c	7c	2.18
12-Jun	311c	1c	0.43
11-Jun	312c	10c	3.06
10-Jun	322c	0	0

Stock Checklist

Price is below from 52 week high low average: 76%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView